Advertisement
Home Authors Posts by HealthDay.com

HealthDay.com

HealthDay.com
38981 POSTS 0 COMMENTS
A new anatomic threshold may be useful for identifying unilateral optic nerve lesions in patients with multiple sclerosis

Thresholds Found for Unilateral Optic Nerve Lesions in MS

0
Intereye differences for retinal nerve fiber layer and macular ganglion cell + inner plexiform layer useful
A new tool

Study Describes TBI Caregiver QOL Measurement System

0
Five new item banks developed to assess health-related quality for traumatic brain injury caregivers
Venetoclax (VENCLEXTA) has been approved to treat adult patients with chronic lymphocytic leukemia or small lymphocytic lymphoma

FDA Approves Venetoclax for Chronic Lymphocytic Leukemia

0
In randomized trial, drug demonstrated statistically significant improvement in progression-free survival
From 2000 to 2015

Estimated Prevalence of Low Birth Weight Down Since 2000

0
However, average annual reduction rate of 1.23 percent insufficient to reach global targets
Teaching patients to wear goggles when symptomatic to videorecord nystagmus can assist with the diagnosis of episodic vestibular disorders

Goggles That Record Nystagmus Could Help Diagnose Vertigo

0
Vestibular event monitoring feasible, could allow accurate diagnosis of episodic vestibular disorders
Indicators of despair are rising among U.S. adults entering midlife

More U.S. Adults Show Signs of Despair As They Enter Middle Age

0
Pattern generalized across races, education levels, geography
North Carolina is suing electronic cigarette manufacturer JUUL for allegedly marketing its products to children and misleading the public about the health risks of the products. This lawsuit is the first filed by a state over JUUL's alleged marketing toward teens

North Carolina Sues Electronic Cigarette Maker JUUL

0
Also, judge has ruled that the FDA neglected its legal duty by postponing reviews of vaping products
Venetoclax (VENCLEXTA) has been approved to treat adult patients with chronic lymphocytic leukemia or small lymphocytic lymphoma

FDA Approves Venetoclax for Chronic, Small Lymphocytic Leukemia

0
In randomized trial, drug demonstrated statistically significant improvement in progression-free survival
Avelumab (BAVENCIO) was approved this week for first-line treatment of advanced renal cell carcinoma in combination with axitinib

Avelumab + Axitinib Approved for Treatment of Renal Cell Carcinoma

0
Treatment combination demonstrated longer progression-free survival versus sunitinib in randomized trial
Guidelines have been updated for screening and treatment for tuberculosis infection among health care personnel

Recs Updated for TB Screening, Treatment in Health Care Workers

0
Guidelines include preplacement TB risk assessment, postexposure symptom evaluation and testing